Journals / Çocuk Cerrahisi Dergisi / 2021 / Cilt: 35 - Sayı: 2

Results of Crystalized Phenol Application in the Treatment of Pilonidal Sinus Disease in Children: Our Single Center Experience

Çocuklarda Pilonidal Sinüs Hastalığı Tedavisinde Kristalize Fenol Uygulaması Sonuçları Tek Merkez Deneyimlerimiz

Pages
65–70
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Keywords: Pilonidal sinus disease, crystallized phenol, child

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The debate about the etiology of Pilonidal Sinus Disease (PSD) continues over whether the disease is congenital or acquired.
📊
Key Findings & Data:Method: The 6-month follow-up results of patients who were treated with crystallized phenol (CF) application with the diagnosis of PSD between March 2020 and August 2020 in the Pediatric Surgery Clinic were retrospectively analyzed.
💡
Conclusion & Impact:Keywords: Pilonidal sinus disease, crystallized phenol, child
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The debate about the etiology of Pilonidal Sinus Disease (PSD) continues over whether the disease is congenital or acquired. After determining the etiologic factora, new pilonidal sinus treatment methods have been developed. Method: The 6-month follow-up results of patients who were treated with crystallized phenol (CF) application with the diagnosis of PSD between March 2020 and August 2020 in the Pediatric Surgery Clinic were retrospectively analyzed. The patients were evaluated by age, height, weight, gender, body mass index, number of sinus mouths, sinus mouth width, sacral cupping distance and cyst diameter by imaging method and pilonidal sinus area measurement. After three consecutive weeks of CF administration, a two-week break was given. Every three weeks of treatment was considered as one treatment cycle. CF treatment was considered unsuccessful for patients whose pilonidal sinus cavity was not closed at the end of three cycles and the complaint of discharge persisted. Results: During the study period, 21 patients with PSH and a maximum of three sinus orifices were treated with CF in our clinic. Including 15 (71.4%) male and 6 (18.6%) female cases. The median age of the patients was 16 (14-17.5) years. In two patients (9.5%) who received three cycles of treatment, the treatment was considered as CF treatment failure because of the persistence of discharge complaints, and surgical treatment was planned for the patient. In the findings obtained as a result of the follow-up of the patients, it was observed that three patients (14.2%) had temporary painless transient dermatitis during follow-up due to phenol applied. Conclusion: The application of CF in the PSD treatment in pediatric age group should be considered as an acceptable method that can be easily applied by any surgeon with its short hospital stay, its applicability under local anesthesia in outpatient clinic conditions, low postoperative complications, high success rates, and low cost. Keywords: Pilonidal sinus disease, crystallized phenol, child

Özet

Amaç: Pilonidal Sinüs Hastalığının (PSH) etiyolojisi hakkındaki tartışma, hastalığın doğuştan mı yoksa edinilmiş mi olduğu üzerine devam etmektedir. Etiyolojik nedenlerin belirlenmesinden sonra yeni pilonidal sinüs tedavi yöntemleri gelişmiştir. Yöntem: Mart 2020-Agustos 2020 tarihleri arasında çocuk cerrahi kliniğinde PSH tanısı ile kristalize fenol (KF) tedavisi uygulanan hastaların 6 aylık takip sonuçları retrospektif olarak incelenmiştir. Hastaların yaş, boy, kilo, cinsiyet, beden kitle indeksi, sinüs ağzı sayısı, sinüs ağzı genişliği, sakral çukurluk mesafesi ve görüntüleme yöntemi ile kist çapı ile pilonidal sinüs alanı ölçümü ile değerlendirme yapıldı. Üç hafta ardışık KF uygulamasından sonra iki hafta ara verildi. Her üç haftalık tedavi bir kür olarak kabul edildi. Üç kür sonunda pilonidal sinus boşluğu kapanmayan ve akıntı yakınması devam eden hastalar için KF tedavisi başarısız olarak değerlendirildi. Bulgular: Çalışma dönemi tarihleri arasında kliniğimizde PSH ve en fazla üç sinüs ağzı olan toplam 21 hastaya KF tedavisi uygulandı. KF tedavisi uygulanan hastaların 15’i (%71,4) erkek 6’sı (%18,6) kız idi. Hastaların yaş ortancası 16 (14-17,5) yaş idi. Üç kür tedavi uygulanan iki hastada (%9,5) akıntı yakınmalari devam etmesi nedeniyle tedavi KF tedavisi başarısızlığı olarak değerlendirilerek hastaya cerrahi tedavi planlandı. Hastaların takipleri sonucu elde edilen bulgularda üç hastada (14,2%) uygulanan fenole bağlı ciltte ağrısız geçici dermatit olduğu görüldü. Sonuç: Çocuk yaş grubunda PSH tedavisinde KF uygulaması, kısa hastanede kalış süresi, poliklinik şartlarında lokal anestezi altında uygulanabilir olması, işlem sonrası düşük komplikasyon ve yüksek başarı oranları ve düşük maliyetli ile her cerrah tarafından kolayca uygulanabilecek kabul edilebilir bir yöntem olarak değerlendirilmelidir. Anahtar kelimeler: Pilonidal sinüs hastalığı, kristalize fenol, çocuk

🔖

Cite This Article

BALTRAK, Y. A., SÖĞÜT, S. E., VARLIKLI, O. (2021). Results of Crystalized Phenol Application in the Treatment of Pilonidal Sinus Disease in Children: Our Single Center Experience. Çocuk Cerrahisi Dergisi, Cilt: 35 - Sayı: 2, 65–70. https://ajindex.com/articles/413627

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hendren S, Hammond K, Glasgow SC, Perry WB, Buie WD, Steele SR, et al. Clinical practice guidelines for ostomy surgery. Dis Colon Rectum 2015;58:375-87.
  2. Bascom J. Pilonidal disease: origin from follicles of hairs and re- sults of follicle removal as treatment. Surgery 1980;87:567-72
  3. Kanat BH, Sözen S. Disease that should be remembered: Sacro- coccygeal pilonidal sinus disease and short history. World J Clin Cases 2015;3:876-9.
  4. Nordon IM, Senapati A, Cripps NP. A prospective randomized controlled trial of simple Bascom’s technique versus Bascom’s cleft closure for the treatment of chronic pilonidal disease. Am J Surg 2009;197:189-92.
  5. Kayaalp C, Aydin C. Review of phenol treatment in sacrococ- cygeal pilonidal disease. Tech Coloproctol. 2009;13:189-93.
  6. Goodall P. The aetiology and treatment of pilonidal sinus. A re- view of 163 patients. Br J Surg 1961;49:212-8.
  7. Cengiz T. Endodonti 4. Baskı, Barış Yayınları, İzmir, 267, 1996
  8. Lahoud CA, March JA, Proctor DD. Campho-Phenique ingestion: an intentional overdose. South Med J 1997;6:647-8.
  9. Aksoy HM, Aksoy B, Egemen D. Effectiveness of topical use of natural polyphenols for the treatment of sacrococcygeal pilonidal sinus disease: a retrospective study including 192 patients. Eur J Dermatol 2010;20:476-81.
  10. Kaymakcioglu N, Yagci G, Simsek A, Unlu A, Tekin OF, Cetiner S, et al. Treatment of pilonidal sinus by phenol application and factors af- fecting the recurrence. Tech Coloproctol 2005;9:21-4.
  11. Topuz O, Sözen S, Tükenmez M, Topuz S, Vurdem UE. Crystallized phenol treatment of pilonidal disease improves quality of life. Indian J Surg 2014;76:81-4.
  12. Dag A, Colak T, Turkmenoglu O, Sozutek A, Gundogdu R. Phenol procedure for pilonidal sinus disease and risk factors for treatment failure. Surgery 2012;151:113-7.
  13. Akan K, Tihan D, Duman U, Özgün Y, Erol F, Polat M. Comparison of surgical Limberg flap technique and crystallized phenol application in the treatment of pilonidal sinus disease: a retrospective study. Ulusal Cer Derg. 2013;29:162-6. https://doi.or